Oxybro 100 Capsule contains Acebrophylline 100 mg, a bronchodilator and mucolytic agent used primarily in the management of respiratory conditions characterized by bronchospasm and excessive mucus production, such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. Acebrophylline acts by relaxing the smooth muscles of the bronchial airways, thereby facilitating easier airflow and improving breathing. Additionally, it exhibits mucolytic properties that help in breaking down thick mucus, enhancing its clearance from the respiratory tract and reducing airway obstruction. The drug also possesses anti-inflammatory effects, which contribute to reducing airway inflammation and improving overall lung function. Oxybro 100 is typically administered orally, with dosage tailored according to the severity of the condition and patient response. It is generally well-tolerated, but potential side effects may include gastrointestinal disturbances, headache, or allergic reactions in sensitive individuals. Caution is advised in patients with known hypersensitivity to xanthine derivatives or those with cardiac arrhythmias. Oxybro 100 Capsule should be used under medical supervision, ensuring proper diagnosis and monitoring to optimize therapeutic outcomes and minimize adverse effects.